Review: Pharmacological pollution in water

Critical Reviews in Environmental Science and Technology

Volumn 43, Issue 10, 2013, Pages 1074-1116

  Kaplan, Samuel ^a  

^a RHODE ISLAND DEPARTMENT OF ENVIRONMENTAL MANAGEMENT   (United States)

Author keywords

API; CEC; EDC; EOC; OWC; pharmaceutical pollution; pharmacological pollution; PPCP

Indexed keywords

API; CEC; EDC; EOC; OWC; PPCP;

EFFLUENTS; ENVIRONMENTAL IMPACT; GROUNDWATER; POLLUTION; TISSUE;

RIVER POLLUTION;

ACETYLSALICYLIC ACID; ACTIVATED CARBON; AGENTS AFFECTING LIPID METABOLISM; ANTACID AGENT; ANTIANGINA PECTORIS AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIESTROGEN; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTILIPEMIC AGENT; ANTIPYRETIC AGENT; ANXIOLYTIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CONTRACEPTIVE AGENT; CONTRAST MEDIUM; DRINKING WATER; ESTROGEN; FERTILITY PROMOTING AGENT; GROUND WATER; HORMONE; NICOTINE DERIVATIVE; PARACETAMOL; SEROTONIN UPTAKE INHIBITOR; STEROID; SURFACE WATER; UNINDEXED DRUG;

AGRICULTURAL LAND; BIOSOLID; DRUG; EFFLUENT; ENVIRONMENTAL ASSESSMENT; ENVIRONMENTAL IMPACT; LITERATURE REVIEW; POLLUTANT REMOVAL; POLLUTION MONITORING; REGULATORY APPROACH; RESEARCH AND DEVELOPMENT; SEWAGE TREATMENT; WATER POLLUTION;

ACT; ACTIVATED SLUDGE; AGRICULTURAL LAND; ANALYTIC METHOD; BIOSOLID; CHEMICAL OXYGEN DEMAND; CONSTRUCTED WETLAND; EFFLUENT; ELECTROSPRAY MASS SPECTROMETRY; ENVIRONMENTAL IMPACT; GAS CHROMATOGRAPHY; GOVERNMENT; GOVERNMENT REGULATION; HYGIENE PRODUCT; LD 50; LIQUID LIQUID EXTRACTION; MASS FRAGMENTOGRAPHY; ORGANIC POLLUTION; PHARMACEUTICAL AND PERSONAL CARE PRODUCT; QUADRUPOLE MASS SPECTROMETRY; REVERSE OSMOSIS; REVIEW; SEDIMENT; SLUDGE TREATMENT; SOIL POLLUTION; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY; WASTE COMPONENT REMOVAL; WASTE WATER TREATMENT PLANT; WATER CONTAMINATION; WATER POLLUTANT; WATER POLLUTION; WATER SUPPLY; WATER TREATMENT;

EID: 84875324043     PISSN: 10643389     EISSN: 15476537     Source Type: Journal    
DOI: 10.1080/10934529.2011.627036     Document Type: Review

References (87)

1. Kolpin, D. W. U.S. Geological Survey. Personal communication, November 23, 2010.
2. Daughton, C. G., and Ternes, T. A. (1999). Pharmaceuticals and personal care products in the environment: Agents of subtle change? Environmental Health Perspectives, 107, 907-938. (Pubitemid 30068192)
3. Muñoz, I., Gómez, M. J., Molina-Díaz, A., Huijbregts, M. A. J., Fernández-Alba, A. R., and García-Calvo, E. (2008). Ranking potential impacts of priority and emerging pollutants in urban wastewater through life cycle impact assessment. Chemosphere, 74, 37-44.
4. Snyder, S. A., Westerhoff, P., Yoon, Y., and Sedlak, D. L. (2003). Pharmaceuticals, personal care products, and endocrine disruptors in water: Implications for the water industry. Environmental Engineering Science, 20, 449-469. (Pubitemid 37158352)
5. Daughton, C. G. (2003). Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. I. Rationale for and avenues toward a green pharmacy. Environmental Health Perspectives, 111, 757-774. (Pubitemid 36621608)
6. U.S. Environmental Protection Agency. (2009). Drinking water contaminant candidate list 3-final. EPA-HQ-OW-2007-1189 FRL-8963-6.
7. Daughton, C. G. (2001). Pharmaceuticals and personal care products in the environment: Overarching issues and overview. ACS Symposium Series, 791, 2-38.
8. Halling-Sørensen, B., Nors-Nielsen, S., Lanzky, P. F., Ingerslev, F., Holten- Lützhøft, H. C., and Jørgensen, S. E. (1998). Occurrence, fate and effects of pharmaceutical substances in the environment: A review. Chemosphere, 36, 357-393. (Pubitemid 27514266)
9. Phillips, P. J., Smith, S. G., Kolpin, D. W., Zaugg, S. D., Buxton, H. T., Furlong, E. T., Esposito, K., and Stinson, B. (2010). Pharmaceutical formulation facilities as sources of opioids and other pharmaceuticals to wastewater treatment plant effluents. Environmental Science and Technology, 44, 4910-4916.
10. Heberer, T. (2002). Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: A review of recent research data. Toxicology Letters, 131, 5-17. (Pubitemid 34461906)
11. Holm, J. V., Rügge, K., Bjerg, P. L., and Christensen, T. H. (1995). Occurrence and distribution of pharmaceutical organic compounds in the groundwater downgradient of a landfill (Grindsted, Denmark). Environmental Science and Technology, 29, 1415-1420. (Pubitemid 26437848)
12. Godfrey, E., Woessner, W. W., and Benotti, M. J. (2007). Pharmaceuticals in on-site sewage effluent and ground water, Western Montana. Ground Water, 45, 263-271. (Pubitemid 46675857)
13. Kolpin, D. W., Furlong, E. T., Meyer, M. T., Thurman, E. M., Zaugg, S. D., Barber, L. B., and Buxton, H. T. (2002). Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: A national reconnaissance. Environmental Science and Technology, 36, 1202-1211. (Pubitemid 34228893)
14. Barnes, K. K., Kolpin, D. W., Furlong, E. T., Zaugg, S. D., Meyer, M. T., and Barber, L. B. (2008). A national reconnaissance of pharmaceuticals and other organic wastewater contaminants in the United States: I) groundwater. Science of the Total Environment, 402, 192-200.
15. Fisher, P. M. J., and Scott, R. (2008). Evaluating and controlling pharmaceutical emissions from dairy farms: A critical first step in developing a preventative management approach. Journal of Cleaner Production, 16, 1437-1446.
16. Yoon, Y., Ryu, J., Oh, J., Byeong-Gyu, C., and Snyder, S. A. (2010). Occurrence of endocrine disrupting compounds, pharmaceuticals, and personal care products in the Han River (Seoul, South Korea). Science of the Total Environment, 408, 636-643.
17. Xu, W., Zhang, G., Zou, S., Li, X., and Liu, Y. (2007). Determination of selected antibiotics in the Victoria Harbour and the Pearl River, South China using high-performance liquid chromatography-electrospray ionization tandem mass spectrometry. Environmental Pollution, 145, 672-679. (Pubitemid 46149173)
18. Lin, A. Y., Yu, T., and Lin, C. (2008). Pharmaceutical contamination in residential, industrial, and agricultural waste streams: Risk to aqueous environments in Taiwan. Chemosphere, 74, 131-141.
19. Boyd, G. R., Reemtsma, H., Grimm, D. A., and Mitra, S. (2003). Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada. The Science of the Total Environment, 311, 135-149. (Pubitemid 36773740)
20. Kasprzyk-Hordern, B., Dinsdale, R. M., and Guwy, A. J. (2008). The occurrence of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs in surface water in South Wales, UK. Water Research, 42, 3498-3518.
21. Terzić, S., Senta, I., Ahel, M., Gros, M., Petrović, M., Barcelo, D., Müller, J., Knepper, T., Martí, I., Ventura, F., Jovančić, P., and Jabučar, D. (2008). Occurrence and fate of emerging wastewater contaminants in Western Balkan Region. Science of the Total Environment, 399, 66-77.
22. Moldovan, Z. (2006). Occurrences of pharmaceutical and personal care products as micropollutants in rivers from Romania. Chemosphere, 64, 1808-1817. (Pubitemid 44092955)
23. Pal, A., Gin, K. Y., Lin, A. Y., and Reinhard, M. (2010). Impacts of emerging organic contaminants on freshwater resources: Review of recent occurrences, sources, fate and effects. Science of the Total Environment, 408, 6062-6069.
24. Daughton, C. G. (2007). Chapter 1: Pharmaceuticals in the environment: Sources and their management. In M. Petrović and D. Barceló (Eds.), Analysis, fate and removal of pharmaceuticals in the water cycle (pp. 1-60). Boston, MA: Elsevier.
25. Carballa, M., Omil, F., and Lema, J. M. (2007). Calculation methods to perform mass balances of micropollutants in sewage treatment plants. Application to pharmaceutical and personal care products (PPCPs). Environmental Science and Technology, 41, 884-890. (Pubitemid 46208525)
26. Ternes, T. A., Joss, A., and Siegrist, H. (2004). Peer reviewed: Scrutinizing pharmaceuticals and personal care products in wastewater treatment. Environmental Science and Technology, 38, 392A-399A. (Pubitemid 39382662)
27. Petrović, M., Gonzalez, S., and Barceló, D. (2003). Analysis and removal of emerging contaminants in wastewater and drinking water. Trends in Analytical Chemistry, 22, 685-696. (Pubitemid 37509935)
28. Ternes, T. A., Meisenheimer, M., McDowell, D., Sacher, F., Brauch, H., Haist- Gulde, B., Preuss, G., Wilme, U., and Zulei-Seibert, N. (2002). Removal of pharmaceuticals during drinking water treatment. Environmental Science and Technology, 36, 3855-3863. (Pubitemid 35006342)
29. Miao, X., Koenig, B. G., and Metcalfe, C. D. (2002). Analysis of acidic drugs in the effluents of sewage treatment plants using liquid chromatography-electrospray ionization tandem mass spectrometry. Journal of Chromatography A, 952, 139-147. (Pubitemid 34266880)
30. Loftin, K. U.S. Geological Survey. Personal communication, April 21, 2010.
31. Hao, C., Zhao, X., and Yang, P. (2007). GC-MS and HPLC-MS analysis of bioactive pharmaceuticals and personal-care products in environmental matrices. Trends in Analytical Chemistry, 26, 569-580. (Pubitemid 46891088)
32. Miao, X., and Metcalfe, C. D. (2007). Analysis of neutral and acidic pharmaceuticals by liquid chromatography mass spectrometry. In M. Petrović and D. Barceló (Eds.), Analysis, fate and removal of pharmaceuticals in the water cycle (pp. 133-157). Boston, MA: Elsevier.
33. Esperanza, M., Suidan, M. T., Nishimura, F., Wang, Z., Sorial, G. A., Zaffiro, A., McCauley, P., Brenner, R., and Sayles, G. (2004). Determination of sex hormones and nonylphenol ethoxylates in the aqueous matrixes of two pilot-scale municipal wastewater treatment plants. Environmental Science and Technology, 38, 3028-3035. (Pubitemid 38691701)
34. Daughton, C. G. (2010). Chapter 2: Pharmaceutical ingredients in drinking water: Overview of occurrence and significance of human exposure. In R. Halden (Ed.), Contaminants of emerging concern in the environment: Ecological and human health considerations (pp. 9-57). Washington, DC: American Chemical Society.
35. Miège, C., Choubert, J. M., Ribeiro, L., Eusèbe, M., and Coquery, M. (2009). Fate of pharmaceuticals and personal care products in wastewater treatment plants: Conception of a database and first results. Environmental Pollution, 157, 1721-1726.
36. Lishman, L., Smyth, S. A., Sarafin, K., Kleywegt, S., Toito, J., Peart, T., Lee, B., Servos, M., Beland, M., and Seto, P. (2006). Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada. Science of the Total Environment, 367, 544-558. (Pubitemid 44109889)
37. Onesios, K. M., Yu, J. T., and Bouwer, E. J. (2009). Biodegradation and removal of pharmaceuticals and personal care products in treatment systems: A review. Biodegradation, 20, 441-466.
38. Matamoros, V., García, J., and Bayona, J. M. (2008). Organic micropollutant removal in a full-scale surface flow constructed wetland fed with secondary effluent. Water Research, 42, 653-660. (Pubitemid 351625263)
39. Sipma, J., Osuna, B., Collado, N., Monclus, H., Ferrero, G., Comas, J., and Rodriguez-Roda, I. (2010). Comparison of removal of pharmaceuticals in MBR and activated sludge systems. Desalination, 250, 653-659.
40. Reif, R., Suárez, S., Omil, F., and Lema, J. M. (2008). Fate of pharmaceuticals and cosmetic ingredients during the operation of a MBR treating sewage. Desalination, 221, 511-517.
41. Carballa, M., Omil, F., Ternes, T., and Lema, J. M. (2007). Fate of pharmaceutical and personal care products (PPCPs) during anaerobic digestion of sewage sludge. Water Research, 41, 2139-2150. (Pubitemid 46601560)
42. Carballa, M., Manterola, G., Larrea, L., Ternes, T., Omil, F., and Lema, J. M. (2007). Influence of ozone pre-treatment on sludge anaerobic digestion: Removal of pharmaceutical and personal care products. Chemosphere, 67, 1444-1452. (Pubitemid 46227511)
43. Kim, I., and Tanaka, H. (2009). Photodegradation characteristics of PPCPs in water with UV treatment. Environment International, 35, 793-802.
44. Pereira, V. J., Weinberg, H. S., Linden, K. G., and Singer, P. C. (2007). UV degradation kinetics and modeling of pharmaceutical compounds in laboratory grade and surface water via direct and indirect photolysis at 254 nm. Environmental Science and Technology, 41, 1682-1688. (Pubitemid 46362471)
45. Snyder, S. A., Adham, S., Redding, A. M., Cannon, F. S., DeCarolis, J., Oppenheimer, J., Wert, E. C., and Yoon, Y. (2007). Role of membranes and activated carbon in the removal of endocrine disruptors and pharmaceuticals. Desalination, 202, 156-181. (Pubitemid 44829082)
46. Guo, Y. C., and Krasner, S. W. (2009). Occurrence of primidone, carbamazepine, caffeine, and precursors for N-nitrosodimethylamine in drinking water sources impacted by wastewater. Journal of the American Water Resources Association, 45, 58-67.
47. Westerhoff, P., Yoon, Y., Snyder, S., and Wert, E. (2005). Fate of endocrinedisruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes. Environmental Science and Technology, 39, 6649-6663. (Pubitemid 41266148)
48. Yoon, Y., Westerhoff, P., Snyder, S. A., and Wert, E. C. (2006). Nanofiltration and ultrafiltration of endocrine disrupting compounds, pharmaceuticals and personal care products. Journal of Membrane Science, 270, 88-100. (Pubitemid 43112388)
49. Benotti, M. J., Trenholm, R. A., Vanderford, B. J., Holady, J. C., Stanford, B. D., and Snyder, S. A. (2009). Pharmaceuticals and endocrine disrupting compounds in U.S. drinking water. Environmental Science and Technology, 597-603.
50. Ternes, T. A., Bonerz, M., Herrmann, N., Teiser, B., and Andersen, H. R. (2007). Irrigation of treated wastewater in Braunschweig, Germany: An option to remove pharmaceuticals and musk fragrances. Chemosphere, 66, 894-904. (Pubitemid 44803057)
51. Drewes, J. E., Heberer, T., Rauch, T., and Reddersen, K. (2003). Fate of pharmaceuticals during ground water recharge. Ground Water Monitoring & Remediation, 23, 64-72. (Pubitemid 37060619)
52. Fox, P., Houston, S., Westerhoff, P., Drewes, J. E., Nellor, M., Yanko, W., Baird, R., Rincon, M., Arnold, R., Lansey, K., Bassett, R., Gerba, C., Karpiscak, M., Amy, G., and Reinhard, M. (2001). Soil aquifer treatment for sustainable water reuse. Denver, CO: AWWA Research Foundation.
53. Lapen, D. R., Topp, E., Metcalfe, C. D., Li, H., Edwards, M., Gottschall, N., Bolton, P., Curnoe, W., Payne, M., and Beck, A. (2008). Pharmaceutical and personal care products in tile drainage following land application of municipal biosolids. Science of the Total Environment, 399, 50-65.
54. Topp, E., Monteiro, S. C., Beck, A., Coelho, B. B., Boxall, A. B. A., Duenk, P. W., Kleywegt, S., Lapen, D. R., Payne, M., Sabourin, L., Li, H., and Metcalfe, C. D. (2008). Runoff of pharmaceuticals and personal care products following application of biosolids to an agricultural field. Science of the Total Environment, 396, 52-59.
55. Kinney, C. A., Furlong, E. T., Zaugg, S. D., Burkhardt, M. R., Werner, S. L., Cahill, J. D., and Jorgensen, G. R. (2006). Survey of organic wastewater contaminants in biosolids destined for land application. Environmental Science and Technology, 40, 7207-7215. (Pubitemid 44871828)
56. U.S. Environmental Protection Agency, Office of Water. (2000). Biosolids technology fact sheet land application of biosolids. EPA 832-F-00-064.
57. Jones-Lepp, T. and Stevens, R. (2007). Pharmaceuticals and personal care products in biosolids/sewage sludge: The interface between analytical chemistry and regulation. Analytical and Bioanalytical Chemistry, 387, 1173-1183. (Pubitemid 46220403)
58. Kinney, C. A., Furlong, E. T., Werner, S. L., and Cahill, J. D. (2006). Presence and distribution of wastewater-derived pharmaceuticals in soil irrigated with reclaimed water. Environmental Toxicology and Chemistry, 25, 317-326. (Pubitemid 43134232)
59. Ferrer, I., and Furlong, E. T. (2002). Accelerated solvent extraction followed by on-line solid-phase extraction coupled to ion trap LC/MS/MS for analysis of benzalkonium chlorides in sediment samples. Analytical Chemistry, 74, 1275-1280. (Pubitemid 34233315)
60. Burkhardt, M. R., ReVello, R. C., Smith, S. G., and Zaugg, S. D. (2005). Pressurized liquid extraction using water/isopropanol coupled with solid-phase extraction cleanup for industrial and anthropogenic waste-indicator compounds in sediment. Analytica Chimica Acta, 534, 89-100. (Pubitemid 40410558)
61. Guler, Y., and Ford, A. T. (2010). Anti-depressants make amphipods see the light. Aquatic Toxicology, 99, 397-404.
62. Fent, K., Weston, A. A., and Caminada, D. (2006). Ecotoxicology of human pharmaceuticals. Aquatic Toxicology, 76, 122-159. (Pubitemid 43087657)
63. Ericson, H., Thorsén, G., and Kumblad, L. (2010). Physiological effects of diclofenac, ibuprofen and propranolol on Baltic Sea blue mussels. Aquatic Toxicology, 99, 223-231.
64. Saaristo, M., Craft, J. A., Lehtonen, K. K., and Lindström, K. (2010). An endocrine disrupting chemical changes courtship and parental care in the sand goby. Aquatic Toxicology, 97, 285-292.
65. Lindström, K., St. Mary, C. M., and Pampoulie, C. (2006). Sexual selection for male parental care in the sand goby, Pomatoschistus minutus. Behavioral Ecology and Sociobiology, 60, 46-51.
66. Forsgren, E. (1992). Predation risk affects mate choice in a gobiid fish. The American Naturalist, 140, 1041-1049.
67. Fair, P. A., Lee, H., Adams, J., Darling, C., Pacepavicius, G., Alaee, M., Bossart, G. D., Henry, N., and Muir, D. (2009). Occurrence of triclosan in plasma of wild Atlantic bottlenose dolphins (tursiops truncatus) and in their environment. Environmental Pollution, 157, 2248-2254.
68. Wilson, B. A., Smith, V. H., Denoyelles, F., and Larive, C. K. (2003). Effects of three pharmaceutical and personal care products on natural freshwater algal assemblages. Environmental Science and Technology, 37, 1713-1719. (Pubitemid 36534744)
69. Giudice, B. D., and Young, T. M. (2010). The antimicrobial triclocarban stimulates embryo production in the freshwater mudsnail Potamopyrgus Antipodarum. Environmental Toxicology and Chemistry, 29, 966-970.
70. Halden, R. U., and Paull, D. H. (2005). Co-occurrence of triclocarban and triclosan in U.S. water resources. Environmental Science and Technology, 39, 1420-1426. (Pubitemid 40387693)
71. Chen, J., Ahn, K. C., Gee, N. A., Ahmed, M. I., Duleba, A. J., Zhao, L., Gee, S. J., Hammock, B. D., and Lasley, B. L. (2008). Triclocarban enhances testosterone action: a new type of endocrine disruptor? Endocrinology, 149, 1173-1179. (Pubitemid 351397964)
72. Matthiessen, P. (2008). An assessment of endocrine disruption in mollusks and the potential for developing internationally standardized mollusk life cycle test guidelines. Integrated Environmental Assessment and Management, 4, 274-284.
73. Duft, M., Schulte-Oehlmann, U., Weltje, L., Tillmann, M., and Oehlmann, J. (2003). Stimulated embryo production as a parameter of estrogenic exposure via sediments in the freshwater mudsnail Potamopyrgus antipodarum. Aquatic Toxicology, 64, 437-449. (Pubitemid 36876122)
74. Oggier, D. M., Weisbrod, C. J., Stoller, A. M., Zenker, A. K., and Fent, K. (2010). Effects of diazepam on gene expression and link to physiological effects in different life stages in zebrafish Danio rerio. Environmental Science and Technology, 44, 7685-7691.
75. Kallio, J., Lahti, M., Oikari, A., and Kronberg, L. (2010). Metabolites of the aquatic pollutant diclofenac in fish bile. Environmental Science and Technology, 44, 7213-7219.
76. Brooks, B., Chambliss, C. K., Stanley, J. K., Ramirez, A., Banks, K. E., Johnson, R. D., and Lewis, R. J. (2005). Determination of select antidepressants in fish from an effluent-dominated stream. Environmental Toxicology and Chemistry, 24, 464-469. (Pubitemid 40128355)
77. Daughton, C. G. (2003). Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. II. Drug disposal, waste reduction, and future directions. Environmental Health Perspectives, 111, 775-785. (Pubitemid 36621609)
78. US Department of Justice, Office of Public Affairs. (2010, August 19). DEA heads first-ever nationwide prescription drug take-back day. Press release.
79. Benedict, M. U.S. Environmental Protection Agency. Personal communication, November 12, 2010.
80. Carpenter, T. R. U.S. Environmental Protection Agency. Personal communication, May 18, 2010.
81. U.S. Environmental Protection Agency. (2008). Drinking water contaminant candidate list 3-draft; notice. EPA-HQ-OW-2007-1189 FRL-8529-7.
82. U.S. Environmental Protection Agency, Office of Water. (2009). Final contaminant candidate list 3, chemicals: Classification of the PCCL to the CCL. EPA 815-R-09-008.
83. Rudzinski, S. U.S. Environmental Protection Agency. Personal communication, May 10, 2010.
84. U.S. Environmental Protection Agency, Office of Water. (2010). Treating contaminants of emerging concern: A literature review database. EPA-820-R-10-002, EPA.
85. Smith, M. T. U.S. Environmental Protection Agency. Personal communication, July 1, 2010.
86. U.S. Environmental Protection Agency. (2008). 40 CFR Part 260, 261, 264, et al. Amendment to the universal waste rule: Addition of pharmaceuticals; proposed rule. EPA-HQ-RCRA-2007-0932; FRL-8746-2.
87. Kolpin, D. W. U.S. Geological Survey. Personal communication, March 22, 2010.